Literature DB >> 9049227

Analysis of histopathological manifestations of chronic hepatitis C virus infection with respect to virus genotype.

S Mihm1, A Fayyazi, H Hartmann, G Ramadori.   

Abstract

Hepatitis C virus (HCV) causes acute and often chronic hepatitis. On the basis of variations in nucleotide sequence, at least six genotypes and several subtypes have been identified. Histopathologically, chronic HCV infection is characterized by relatively mild hepatic inflammatory activity and a low degree of fibrosis, but hepatic lesions might be accompanied by bile duct damage, intraportal lymphoid aggregates, steatosis, or a combination of these manifestations. The histopathological lesions thus appear quite heterogeneous. To address the question of whether distinct histopathological manifestations are related to particular genotypes of HCV, 90 patients with chronic HCV infection were analyzed regarding histopathological features, biochemical liver parameters, demographic data, and virus genotype. The results revealed a significantly higher prevalence of both steatosis and bile duct lesions among patients infected by HCV type 3a compared to patients infected by types 1a or 1b. Furthermore, the data suggest interrelationships between virus genotype, patient's age, and a history of intravenous drug abuse. However, none of the histopathological manifestations were found to be related to a history of drug abuse. The data further corroborate the relationship of HCV type 1b infection to age, duration of disease, and the degree of fibrosis, respectively. Irrespective of HCV genotype, elevated serum ALT activity was shown to be associated with pronounced inflammatory activity or pronounced steatosis as well. Thus, the current data support the hypothesis that distinct genotypes of HCV appear to be associated with distinct manifestations of disease.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9049227     DOI: 10.1002/hep.510250340

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  58 in total

Review 1.  Hepatitis C virus and metabolic disorder interactions towards liver damage and atherosclerosis.

Authors:  Umberto Vespasiani-Gentilucci; Paolo Gallo; Antonio De Vincentis; Giovanni Galati; Antonio Picardi
Journal:  World J Gastroenterol       Date:  2014-03-21       Impact factor: 5.742

2.  Endotoxin receptor CD14 gene variants and histological features in chronic HCV infection.

Authors:  Eva Askar; Giuliano Ramadori; Sabine Mihm
Journal:  World J Gastroenterol       Date:  2009-08-21       Impact factor: 5.742

Review 3.  Steatosis in chronic hepatitis C: why does it really matter?

Authors:  T Asselah; L Rubbia-Brandt; P Marcellin; F Negro
Journal:  Gut       Date:  2006-01       Impact factor: 23.059

Review 4.  What is expected from the pathologist in the diagnosis of viral hepatitis?

Authors:  Helmut Denk
Journal:  Virchows Arch       Date:  2011-02-26       Impact factor: 4.064

Review 5.  Viral hepatitis: new data on hepatitis C infection.

Authors:  Erzsébet Szabó; Gábor Lotz; Csilla Páska; András Kiss; Zsuzsa Schaff
Journal:  Pathol Oncol Res       Date:  2003-12-22       Impact factor: 3.201

6.  Steatosis and hepatic expression of genes regulating lipid metabolism in Japanese patients infected with hepatitis C virus.

Authors:  Kohichiroh Yasui; Yuichi Harano; Hironori Mitsuyoshi; Kazuhiro Tsuji; Mio Endo; Tomoaki Nakajima; Masahito Minami; Yoshito Itoh; Yoh Zen; Yasuni Nakanuma; Toshikazu Yoshikawa; Takeshi Okanoue
Journal:  J Gastroenterol       Date:  2009-09-30       Impact factor: 7.527

Review 7.  Hepatitis C virus infection: Are there still specific problems with genotype 3?

Authors:  Claire Gondeau; Georges Philippe Pageaux; Dominique Larrey
Journal:  World J Gastroenterol       Date:  2015-11-14       Impact factor: 5.742

8.  Characteristics of hepatitis C virus infection in HIV-infected people.

Authors:  C L Cooper; A D Badley; J B Angel
Journal:  Can J Infect Dis       Date:  2001-05

9.  Inhibition of core gene of HCV 3a genotype using synthetic and vector derived siRNAs.

Authors:  Saba Khaliq; Shah Jahan; Bushra Ijaz; Waqar Ahmad; Sultan Asad; Asim Pervaiz; Baila Samreen; Mahwish Khan; Sajida Hassan
Journal:  Virol J       Date:  2010-11-13       Impact factor: 4.099

10.  Retinol supplements antiviral action of interferon in patients with chronic hepatitis C: a prospective pilot study.

Authors:  Naruaki Kohge; Shuichi Sato; Sachiko Hamamoto; Shuji Akagi; Yasushi Uchida; Tatsuya Miyake; Tomoko Mishiro; Kohichiro Furuta; Naoki Oshima; Junnichi Ishine; Yoshiko Takahashi; Norihisa Ishimura; Ryo Fukuda; Shunji Ishihara; Yuji Amano; Yoshikazu Kinoshita
Journal:  J Clin Biochem Nutr       Date:  2009-12-29       Impact factor: 3.114

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.